IMMU phase 3 data was good and it gained 10% on 10/19. Possible buyout target because it has valuable data from divested cancer companies. Play with $2 support or if it breaks $2.60 resistance then play on $2.40 support. I don't like low-priced stocks like this typically but phase 3 data just came out and anything can happen going up.

 

XNPT bounced 5% at $5 support after falling 10% today. Play on $5 support as today was a red day after a run up from $3.35 to $5.75. There is resistance at $5.60 and if it breaks it can go to $5.90. Its a marginal earnings winner so there is some positive outlook for longs.

 

ZFGN looks like a overreaction on death of a patient who was on the drug. Has some decent support around $10 and with any news that the death was not caused by the drug it can go up very quickly. I would suggest trading small amounts in speculation for a increase in price. Buy around $11 with $1 downside so shares or buy if it gets uptrends to $12 with $10.80 stop loss.

 

XON looking to trade from $33-36 and buy again near $32 if it drops that far. Looking like it is holding good support at average volume. My only concern is I will miss out on bigger profits if I sell early and won't have a good re-entry like what happened before it went up to $38 before falling back down to $32.